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Mechanism of Cargo Selection in the
Cytoplasm to Vacuole Targeting Pathway
(Baba et al., 1997; Scott et al., 1997). In the last decade,
morphological, genetic, and biochemical studies on the
yeast Saccharomyces cerevisiae have demonstrated
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Per E. Stromhaug, and Daniel J. Klionsky1
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Departments of Molecular, Cellular, that autophagy, peroxisome degradation (pexophagy),
and the Cvt pathway share a common mechanism forand Developmental Biology and
of Biological Chemistry and biogenesis of the double-membrane vesicles that se-
quester cargo from the cytoplasm (Klionsky and Oh-The Life Sciences Institute
Ann Arbor, Michigan 48109 sumi, 1999; Reggiori and Klionsky, 2002). However, the
mechanism used to selectively incorporate cargo into
these vesicles has been unclear.
Recently, a novel protein, termed Cvt19, has beenSummary
identified and characterized as a receptor for the Cvt
cargos, prApe1 and -mannosidase (Ams1) (HutchinsThe proper functioning of eukaryotic organelles is
largely dependent on the specific packaging of cargo and Klionsky, 2001; Scott et al., 2001). Cvt19 is a periph-
eral membrane protein. Unlike typical transmembrane-proteins within transient delivery vesicles. The cyto-
plasm to vacuole targeting (Cvt) pathway is an auto- type receptors that achieve multiple rounds of binding
and release, Cvt19 is transported to the vacuole alongphagy-related trafficking pathway whose cargo proteins,
aminopeptidase I and -mannosidase, are selectively with its cargo and is degraded by vacuolar proteinases.
Biochemical and fluorescence microscopy analyses in-transported from the cytoplasm to the lysosome-like
vacuole in yeast. This study elucidates a molecular dicate that Cvt19 primarily localizes at a perivacuolar
preautophagosomal structure (PAS), a predicted site ofmechanism for cargo specificity in this pathway involv-
ing four discrete steps. The Cvt19 receptor plays a vesicle formation, where most components required for
autophagy and the Cvt pathway localize (Scott et al.,central role in this process: distinct domains in Cvt19
recognize oligomerized cargo proteins and link them 2001, Suzuki et al., 2001; Kim et al., 2002; Noda et al.,
2002). From these results, Cvt19 is suggested to functionto the vesicle formation machinery via interaction with
Cvt9 and Aut7. Because autophagy is the primary at the step where the Cvt complex is targeted to the
PAS. However, it is not clear how Cvt19 localizes tomechanism for organellar turnover, these results offer
insights into physiological processes that are critical this site. Although components specific for the Cvt and
pexophagy pathways, such as Cvt9, have been identi-in cellular homeostasis, including specific packaging
of damaged or superfluous organelles for lysosomal fied (Scott et al., 2000; Kim et al., 2001b; Nice et al.,
2002), the relationship between Cvt19 and these pro-delivery and breakdown.
teins remains unknown.
In this study, we addressed the molecular mechanismIntroduction
of selective transport of Cvt cargos to the vacuole. The
mapping of functional domains in Cvt19 identified sepa-Macroautophagy is a cellular process responsible for
bulk degradation of cytoplasmic components in eukary- rate binding sites for interaction with two cargo proteins
(prApe1 and Ams1), the Cvt pathway/pexophagy-spe-otic cells. In this process, cytoplasmic materials are
nonselectively sequestered by a double-membrane ves- cific factor Cvt9 and the Cvt vesicle/autophagosome
component Aut7. Using this, together with fluorescenceicle, the autophagosome, and transported to the lyso-
some/vacuole to be degraded (Klionsky and Ohsumi, microscopy analyses and affinity isolation, we conclude
that the process of selective cargo targeting to the PAS1999). Autophagy (Apg) is induced under starvation con-
ditions. Organelles also undergo selective removal by involves a specific subset of Apg/Cvt proteins that act
in a particular temporal order to allow the formation ofautophagy when they are damaged or no longer needed
(Klionsky and Emr, 2000). In addition, vacuolar resident the Cvt complex (Ape1-Cvt19-Ams1) and its incorpora-
tion into sequestering vesicles.enzymes exploit an autophagy-related process called
the cytoplasm to vacuole targeting (Cvt) pathway (Klion-
sky and Ohsumi, 1999). Aminopeptidase I (Ape1), a Results
cargo of the Cvt pathway, is synthesized in the cyto-
plasm as a precursor form (prApe1). The prApe1 propep- GFP-Ape1 Is Transported to the Vacuole
tide contains vacuolar targeting information (Oda et al., by the Cvt and Autophagy Pathways
1996; Segui-Real et al., 1995). After synthesis, prApe1 Aminopeptidase I (Ape1) is a resident hydrolase that
assembles into a dodecamer (Kim et al., 1997), which travels to the vacuole via the cytoplasm to vacuole tar-
is further packaged into a unique structure called the geting (Cvt) pathway. Its N-terminal propeptide contains
Cvt complex (Baba et al., 1997). This complex is subse- vacuolar targeting information and is cleaved off in a
quently enwrapped by a double membrane to form the vacuolar proteinase A (Pep4)-dependent manner subse-
Cvt vesicle. This vesicle then fuses with the vacuole to quent to delivery (Figure 1A, lanes 2 and 5; Klionsky et
release the inner single-membrane vesicle, the Cvt body al., 1992; Oda et al. 1996). To date, most studies of
autophagy have concentrated on analyses of the vesi-
cle-forming machinery. To learn more about the Cvt and1Correspondence: klionsky@umich.edu
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Figure 1. GFP-Ape1 Travels to the Vacuole via the Cvt Pathway
(A) Cell extracts from ape1 (lanes 1–3), pep4 ape1 (lanes 4–6), apg1 ape1 (lane 7), and cvt19 ape1 (lane 8) strains containing either
empty vector (pRS414; lanes 1 and 4), pApe1 (lanes 2 and 5), or pGFP-Ape1 (lanes 3, 6, 7, and 8) were resolved by SDS-PAGE. Western blots
were performed with anti-Ape1 antiserum.
(B) Western blot of cell extracts from pep4 ape1 (lane 1), pep4 (lane 2), ape1 (lane 3), and wild-type (lane 4) strains containing pGFP-
Ape1 with anti-Ape1 (left panel) and anti-GFP (right panel) antisera. An asterisk (*) indicates nonspecific bands.
(C) Localization of Ape1 by fluorescence microscopy of wild-type, pep4, apg1, and cvt19 strains expressing GFP-Ape1. Cells were grown
to midlog phase and labeled with FM 4-64 in SCD medium. Bar, 5 m.
(D) CFP-Ape1 colocalizes with YFP-Aut7 in apg1 cells, but not in cvt19 cells. The apg1 and cvt19 cells coexpressing CFP-Ape1 and
YFP-Aut7 were grown in SCD medium to midlog phase and examined with fluorescence and DIC microscopy. Bar, 5 m.
Apg pathways, we decided to examine import of the 1B, lane 1). These results indicated that GFP-Ape1 was
processed to mApe1 in a vacuolar proteinase-depen-cargo protein precursor Ape1 (prApe1) in vivo. Accord-
ingly, we constructed an N-terminal green fluorescent dent manner, although not as efficiently as the native
protein.protein (GFP) fusion with prApe1. The resulting GFP-
Ape1 chimera was expressed under the control of the To further confirm whether the processing of GFP-
Ape1 was dependent on the Cvt pathway, we next ex-endogenous APE1 promoter from a single-copy plas-
mid. To verify that this construct reflected the trafficking pressed GFP-Ape1 in ape1 apg1 and ape1 cvt19
strains. Apg1 is a Ser/Thr protein kinase essential for Cvtof the native prApe1 protein, we first examined the pro-
cessing of GFP-Ape1 in the ape1 background. Western vesicle/autophagosome formation (Scott et al., 2000;
Kamada et al., 2000). Cvt19 has recently been demon-blot analysis revealed that about 50% of GFP-Ape1 was
processed by cleavage of the prApe1 propeptide, re- strated to function as a receptor for cargo proteins that
utilize the Cvt pathway (Scott et al., 2001; Leber et al.,sulting in the production of the mature form of Ape1
(mApe1) and GFP (Figures 1A and 1B, lane 3). Under the 2001). In both strains, GFP-Ape1 remained in the unpro-
cessed form (Figure 1A, lanes 7 and 8), indicating thatsame conditions, authentic prApe1 was fully processed
(Figure 1A, lane 2). In ape1 pep4 cells, no processing GFP-Ape1 is delivered to the vacuole via the Cvt path-
way. Precursor Ape1 assembles into a dodecamer in theof GFP-Ape1 was observed (Figure 1A, lane 6 and Figure
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cytosol (Kim et al., 1997). Because GFP-Ape1 seemed to in the perivacuolar region (Figure 1C). To determine
be less-efficiently processed than authentic prApe1 in whether GFP-Ape1 was concentrated at a site other
ape1 cells, we examined the effect of the presence than the PAS in the cvt19 strain, we transformed this
of endogenous prApe1 on GFP-Ape1 processing. GFP- strain with CFP-Ape1 and YFP-Aut7. As shown in Figure
Ape1 was expressed in wild-type and pep4 cells and 1D, CFP-Ape1 was not seen at the PAS labeled with
analyzed by Western blot with both anti-Ape1 and anti- YFP-Aut7 in the cvt19 strain. This separate localization
GFP antisera. In pep4 cells, the processing of both was also observed in an apg1 cvt19 strain (data not
GFP-Ape1 and endogenous prApe1 was blocked (Figure shown), indicating that cvt19 is epistatic to apg1 in con-
1B, lane 2), whereas more than 95% of GFP-Ape1 was trolling prApe1 localization to the PAS. These results
converted to mApe1 in the wild-type cells (Figure 1B, suggested that prApe1 formed a large complex (referred
lane 4). These results indicated that the presence of to as the Ape1 complex) independent of Cvt19. How-
endogenous prApe1 facilitated the processing of GFP- ever, the Cvt19 protein is required for the recruitment
Ape1. The GFP-tagging adjacent to prApe1 may affect of the Ape1 complex to the PAS, in agreement with its
some function of the propeptide, e.g., the interaction presumed role as a receptor.
with other proteins (see below; Scott et al., 2001), which
can be restored by the formation of an oligomer with The prApe1 Propeptide Is Required for Its Proper
native prApe1. Localization and the Interaction
We next investigated the localization of GFP-Ape1 in with a Receptor Protein
wild-type and apg/aut/cvt mutant strains. Cells express- The prApe1 propeptide is essential for prApe1 import
ing GFP-Ape1 were labeled with the dye FM 4-64, to to the vacuole but is not required for its oligomerization
visualize the vacuole membrane, and examined by fluo- (Oda et al., 1996; Kim et al. 1997). A secondary-structure
rescence microscopy. In wild-type cells, the GFP signal prediction suggested that the prApe1 propeptide forms
was dispersed uniformly in the vacuole with one or a a helix-turn-helix structure and that the first helix (resi-
few tiny dot signals in the perivacuolar region (Figure dues 1–18) exhibits the characteristics of an amphi-
1C), in agreement with the efficient processing of GFP- pathic  helix, which is critical for membrane association
Ape1 (Figure 1B). We further confirmed the import of (Oda et al., 1996). Mutations in this region (e.g., deletions
GFP-Ape1 in pep4 cells that accumulate Cvt bodies of residues 9–11; 9–11) prevent prApe1 from associat-
in the vacuolar lumen. In this strain, several GFP dots ing with the membrane, thus inhibiting its transport to
were seen moving inside the vacuole, indicating GFP- the vacuole. On the other hand, the substitution of pro-
Ape1 is present within the Cvt bodies (Figure 1C). In line to leucine at position 22 (P22L) causes accumulation
contrast, in the apg1 strain, a single larger dot of GFP- of prApe1 on a nonvacuolar membrane structure but
Ape1 appeared in the perivacuolar region, instead of also blocks most of prApe1 import to the vacuole (Oda
inside the vacuolar lumen (Figure 1C). Because GFP- et al., 1996, Scott et al. 1997). We therefore tried to
Ape1 forms a large dot in most apg/aut/cvt mutants determine the stage in the Cvt pathway that was affected
(data not shown), it is likely that prApe1 accumulates by these mutations in the prApe1 propeptide. We first
as a large structure outside the vacuole when the Cvt
decided to verify the localization of prApe1 propeptide
pathway is blocked. These observations were in agree-
mutants using GFP-fused constructs in an ape1 strain
ment with immunoelectron microscopy analyses show-
by fluorescence microscopy. The wild-type GFP-Ape1
ing that prApe1 travels to the vacuole as a part of the
gave a significant vacuolar lumenal staining with addi-Cvt complex (Baba et al., 1997). Taken together, these
tional small punctate signals in the perivacuolar regionresults demonstrated that the vacuolar localization of
(Figure 2A). In contrast, GFP-Ape19–11 distributed uni-GFP-Ape1 is Cvt pathway dependent and that GFP-
formly in the cytosol (Figure 2A), in agreement with previ-Ape1 serves as a valid marker to follow cargo import
ous biochemical analyses. This result suggested thatthrough the Cvt pathway.
the first amphipathic  helix is involved in the formationIt has been reported that many proteins required for
of the Ape1 complex. In contrast, GFP-Ape1P22L gave athe Cvt and/or autophagic pathway localize at least tran-
single large punctate signal away from the vacuole (Fig-siently to the perivacuolar preautophagosomal structure
ure 2A), suggesting that Ape1P22L was still able to form(PAS), which is thought to be a site of vesicle formation
the Ape1 complex but was defective in localization to(Kim et al., 2001b; Suzuki et al., 2001; Noda et al., 2002;
the PAS.Nice et al., 2002). Many Apg/Aut/Cvt proteins accumu-
The localization of GFP-Ape1 in the cvt19 strain islate at the PAS in apg mutant strains. We examined
quite similar to that of GFP-Ape1P22L. This observationapg1 cells expressing CFP-Ape1 and YFP-tagged
suggested that the P22L mutation affects the interactionAut7, one of the PAS components (Kim et al., 2001a;
between prApe1 and Cvt19. While previous data haveSuzuki et al., 2001), by fluorescence microscopy. As
shown that mutations in the prApe1 propeptide affectshown in Figure 1D, CFP-Ape1 localized to the PAS that
import, no studies have verified that the defect is duewas labeled with YFP-Aut7 in the apg1 strain. Because
to a block in the interaction with Cvt19. To test thisthe putative receptor protein Cvt19 also localizes to
hypothesis, we examined the interaction between prApe1the PAS (Kim et al., 2002), we hypothesized that Cvt19
mutants and Cvt19 by two-hybrid analysis and coimmu-interacts with the prApe1 dodecamer at the PAS, leading
noprecipitation. Because of prApe1 homooligomer for-to the formation of the Cvt complex. To test this idea,
mation, we utilized an ape1 strain (YTS110) as a testwe examined the localization of GFP-Ape1 in a cvt19
strain for the two-hybrid analysis. The ape1 cells car-strain by fluorescence microscopy. Unexpectedly, GFP-
rying both Cvt19 and wild-type Ape1 plasmids exhibitedApe1 still accumulated as a single large dot, but a careful
observation revealed that it did not consistently localize growth on an adenine minus plate, indicating that the
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Figure 2. Precursor Ape1 Propeptide Is Required for the Formation of the Ape1 Complex and Interaction With Cvt19
(A) Localization of the propeptide mutants of GFP-Ape1 by fluorescence and DIC microscopy. The ape1 cells harboring pGFP-Ape1, pGFP-
Ape19–11, or pGFP-Ape1P22L were grown to midlog phase and labeled with FM 4-64 in SCD medium. Bar, 5 m.
(B) Two-hybrid analysis of the physical interaction between Ape1 mutants and Cvt19. Wild-type (PJ69-4A) and isogenic ape1 (YTS110) test
strains were transformed with the activation domain (AD) plasmid containing CVT19 and the binding domain (BD) plasmid containing wild-
type or mutant APE1. Transformants were grown on an SC-Leu-Ura plate and replica plated on an SC-Ade-Leu-Ura plate to assess the
interaction-dependent activation of the ADE2 gene. The cells shown here were grown at 30C for 2 days.
(C) Interaction between prApe1 and Cvt19 is mediated by the prApe1 propeptide. Total lysate from the ape1 apg1 cells expressing HA-
Cvt19 and either wild-type or mutant prApe1 from single-copy plasmids under the control of their own promoters were used for immunoprecipita-
tion with anti-HA antibody, and the immunoprecipitates were analyzed by Western blot with anti-Ape1 and anti-HA antisera (IP). The top panel
(Lysate) shows the protein blot of total cell lysate probed with anti-Ape1 antiserum.
two proteins could interact (Figure 2B). In contrast, caused by the P22L mutation would impair the proper
localization of the complex to the PAS and explains theApe19–11 displayed no binding activity with Cvt19 in the
ape1 strain, although it allowed the wild-type test strain phenotype of GFP-Ape1P22L (Figure 2A).
(PJ69-4A) to grow on an adenine minus plate (Figure 2B).
This result suggested that (1) the interaction between
prApe1 and Cvt19 is propeptide-dependent and that (2) The Ape1-Cvt19 Complex Is Targeted
to the PAS by Cvt9an apparent interaction between Ape19–11 and Cvt19 in
a wild-type strain might be mediated by endogenous Autophagy is a nonselective process and enwraps cyto-
plasm nonspecifically. In contrast, the Cvt pathway andprApe1. Ape1P22L provided much slower growth than
wild-type Ape1 in an ape1 strain, suggesting that the import of prApe1 by autophagy are specific, presumably
because of the interaction between prApe1 and Cvt19.P22L mutation severely affected, but did not completely
block, the interaction between prApe1 and Cvt19 (Figure However, the domain within Cvt19 that binds prApe1 is
not known. Moreover, the precise localization of Cvt192B). We verified these results by coimmunoprecipitation
under native conditions. In this experiment, we used an at the PAS seems to be an important event for selective
targeting of prApe1, which allows us to hypothesize thatapg1 strain to block the Cvt pathway; an Ape1-Cvt19
complex would be degraded in a wild-type strain as a there is a domain in Cvt19 that determines its localization
at the PAS. For these reasons, we tried to identify func-consequence of its import into the vacuole (Scott et al.,
2001; Figure 5A). The ape1 apg1 cells were trans- tional domains within the Cvt19 protein. Cvt19 is a 415-
amino acid protein containing a predicted coiled-coilformed with HA-tagged Cvt19 and wild-type or mutant
prApe1 plasmids, and their extracts were used for immu- domain between amino acids 160 and 187 (Figure 3A).
We constructed several Cvt19 N- and C-terminal dele-noprecipitation with anti-HA antibody. The wild-type
prApe1 was effectively coimmunoprecipitated with HA- tion mutants, e.g., Cvt1915C indicates a mutant lacking
the C-terminal 15 amino acids. Because a coiled-coilCvt19. In contrast, no prApe19–11 and only a small
amount of Ape1P22L was found to coprecipitate with motif often mediates a protein-protein interaction, we
also constructed the Cvt19CC mutant that lacks the 39-Cvt19 (Figure 2C), confirming that the interaction of
prApe1 and Cvt19 was mediated by the prApe1 propep- amino acid region from residues 153 to 191, containing
a coiled-coil domain (Figure 3A). The prApe1 bindingtide. The reduced association of prApe1 with Cvt19
Cargo Selection in the Cvt Pathway
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Figure 3. Mapping Functional Domains within Cvt19
(A) Mapping the prApe1 binding domain by a yeast two-hybrid system. The cvt19 test strain (YTS111) was transformed with the binding
domain plasmid containing the entire APE1 ORF and the activation domain plasmid containing mutant CVT19. The interaction was assessed
by measuring the interaction-dependent induction of -galactosidase activity. CC, coiled coil; ND, not determined.
(B) Total lysates from the apg1 cvt19 cells expressing either wild-type or mutant Cvt19 fused with protein A (ProtA-Cvt19) were used to
precipitate ProtA-Cvt19 proteins with IgG Sepharose. The left and right panels show the protein blots of total cell extracts (Lysate) and the
IgG precipitates (Bound), respectively, which were probed with anti-Ape1 antiserum. Single arrowheads show ProtA-Cvt19 derivatives, and
a double arrowhead indicates protein A without fusion. Although Cvt19 mutants containing the coiled-coil domain (10C, 15C, 20C, 28C,
21–28C, 224C, and 152N) were all able to precipitate prApe1, only the results from 224C and 152N mutants were shown in this figure.
(C) Protein blots of total lysates from the cvt19 cells expressing Cvt19 deletion mutants fused with GFP probed with anti-Ape1 (upper panel)
and anti-GFP (lower panel) antisera. An asterisk (*) indicates nonspecific bands.
(D) Localization of wild-type and mutant Cvt19 proteins by fluorescence and DIC microscopy of cvt19 strains expressing wild-type or mutant
GFP-Cvt19. Cells were grown to midlog phase and labeled with FM 4-64 in SCD medium. Bar, 5 m.
(E) Colocalization of YFP-Cvt19 and YFP-Cvt1920C with CFP-Ape1 and CFP-Aut7 in a cvt19 strain by fluorescence and DIC microscopy. Bar,
5 m.
domain was first examined by a yeast two-hybrid sys- with prApe1 and mutant Cvt19 plasmids, and -galac-
tosidase activity was measured to assess the interac-tem. The cvt19 test strain with the lacZ gene under the
control of a Gal4-dependent promoter was transformed tion. All the Cvt19 proteins containing the coiled-coil
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domain effectively interacted with prApe1, whereas the transported to the vacuole together with prApe1 through
the PAS. The localization of GFP-Cvt19152N was quiteones lacking this domain did not exhibit any interaction
(Figure 3A). To verify these results, we performed an similar to that of wild-type GFP-Cvt19, consistent with
its significant activity for prApe1 import (Figure 3D). Inaffinity isolation experiment. The apg1mutant is defec-
tive in the Cvt pathway and autophagy. In an apg1 contrast to the cells expressing GFP-Cvt19152N, two
populations were observed in the cells expressing GFP-background neither Cvt19 nor prApe1 will be delivered
to the vacuole, thus maintaining similar levels of func- Cvt1910C, although the activities for prApe1 import were
comparable between these two mutants. About half oftional and nonfunctional Cvt19 proteins within the cyto-
sol. Lysates were generated from apg1 cvt19 cells the cells expressing GFP-Cvt1910C had slightly GFP-
stained vacuoles, with a single prominent dot adjacentexpressing protein A-fused Cvt19 truncates, and Cvt19
proteins were isolated with IgG Sepharose. Western blot to the vacuole, and the rest had a single GFP dot away
from the vacuole (Figure 3D). The 15C, 20C, andanalysis of the resulting samples with anti-Ape1 antise-
rum revealed that only the Cvt19 proteins containing 224C proteins, containing the putative coiled-coil do-
main, formed a prominent dot away from the vacuolethe coiled-coil domain were able to precipitate prApe1
(Figure 3B). These results suggest that the coiled-coil (Figure 3D). In contrast, GFP-Cvt19263 and GFP-
Cvt19CC displayed a dispersed cytosolic localization,domain of Cvt19 mediates the interaction between
prApe1 and Cvt19. suggesting that the punctate localization of Cvt19 de-
pends on the interaction with prApe1 (Figure 3D). Con-We decided to extend the analysis by determining the
functionality and the localization of the Cvt19 truncates. sistent with the data presented in Figures 3A and 3B,
the wild-type and YFP-Cvt19 mutants containing theAccordingly, we constructed N-terminal GFP fusions to
Cvt19 and expressed them under the control of the en- coiled-coil domain, such as YFP-Cvt1920C, colocalized
with CFP-Ape1 (Figure 3E, upper panel). However, unlikedogenous Cvt19 promoter from a single-copy plasmid
in cvt19 cells. Western blot analysis of cell extracts YFP-Cvt19, YFP-Cvt1920C did not colocalize with the
CFP-Aut7 dot (Figure 3E, lower panel). These resultswith anti-GFP antibody confirmed that the different GFP-
Cvt19 mutants had similar expression levels (Figure 3C). suggested that prApe1 and Cvt19 form a complex before
recruitment to the PAS. Furthermore, the C-terminal re-The steady-state protein level of GFP-Cvt19 seemed to
be lower than those of the deletion mutants (Figure 3C, gion of Cvt19 is crucial for the proper localization of the
complex to the PAS.lower panel), which was probably because of the effec-
tive transport of GFP-Cvt19 to the vacuole and subse- Recently, it has been reported that Aut7 physically
interacts with Cvt19 (Kim et al., 2002). We hypothesizedquent degradation. Moreover, GFP-Cvt19 exhibited
enough activity for prApe1 maturation (Figure 3C, upper that this interaction could play an important role in the
localization of prApe1 to the PAS and its subsequentpanel), confirming that the GFP-Cvt19 construct is suit-
able for this analysis. About 40% of prApe1 was con- vacuolar import. We therefore mapped the Aut7 binding
domain within Cvt19 by both a yeast two-hybrid systemverted to mApe1 in the cells expressing GFP-Cvt1910C,
and only a small amount of mApe1 was found in the and a protein A affinity isolation experiment. In the two-
hybrid analysis, Aut7 displayed a significant interactioncells expressing GFP-Cvt1915C or GFP-Cvt1920C (Figure
3C, upper panel). In contrast, GFP-Cvt1928C, GFP- with full-length Cvt19 on the basis of the activation of
the ADE2 gene, but did not show significant interactionCvt19224C, GFP-Cvt19263C, and GFP-Cvt19CC failed to
complement the defect in prApe1 maturation in cvt19 with any of the Cvt19 C-terminal truncates (Figure 4A).
An affinity isolation experiment also indicated that pro-cells (Figure 3C, upper panel). Surprisingly, GFP-
Cvt19152N was still partly functional in prApe1 maturation tein A-Aut7 was able to coprecipitate full-length Cvt19,
but the efficiencies were severely reduced for the trun-(Figure 3C, upper panel), indicating that a large N-ter-
minal portion of Cvt19 is dispensable, at least for prApe1 cated Cvt19 proteins, including Cvt1910C (Figure 4B).
These results suggested that the Aut7 binding domaintransport. Even though many mutants, including Cvt1928C,
exhibited a significant interaction with prApe1 (Figures of Cvt19 might be located within, or include, the last
10 C-terminal amino acids. The C-terminally truncated3A and 3B), prApe1 transport was completely lost in
these strains, including cells expressing Cvt1928C. GFP-Cvt19 chimeras were not localized to the PAS (Fig-
ure 3D). If this localization resulted from the loss ofThese results suggest that the C-terminal 28 amino
acids of Cvt19 might have some function in prApe1 interaction between Aut7 and Cvt19, the Ape1-Cvt19
complex should not be localized at the PAS in an aut7transport other than association with the prApe1 pro-
peptide. strain. However, fluorescence microscopy of aut7 cells
expressing GFP-Ape1 or GFP-Cvt19 revealed that theWe next determined the localization of the GFP-Cvt19
mutants. The cvt19 cells expressing wild-type or mu- Ape1-Cvt19 complex seemed to be still localized at the
PAS (Figures 4D and 4E), suggesting the existence oftant GFP-Cvt19 proteins were labeled with FM 4-64 and
observed by fluorescence microscopy. As expected another Cvt19 binding partner(s).
The deletion of AUT7 results in a complete loss offrom the data presented in Figure 3C, GFP-Cvt19 dis-
played vacuolar straining together with one or a few tiny prApe1 transport during vegetative growth, but starva-
tion can partially restore this defect, even though au-dots in the perivacuolar region (Figure 3D). In addition,
as shown previously (Kim et al., 2002), the colocalization tophagy-dependent protein turnover is still defective.
The reversal of the prApe1 import defect could resultof YFP-Cvt19 with CFP-Aut7 confirmed that Cvt19 local-
ized at the PAS (Figure 3E, lower panel). The deletion from the formation of small and/or aberrant vesicles,
instead of normal autophagosomes, under starvationof APG1 resulted in the concentration of GFP-Cvt19 at
the PAS, as seen with GFP-Ape1 in the apg1 strain conditions (Kirisako et al., 1999; Abeliovich et al., 2000).
These data indicate that the specific import of prApe1(Figure 5B). This result suggests that Cvt19 might be
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Figure 4. Cvt9 Facilitates the Localization of the Ape1-Cvt19 Complex to the Preautophagosomal Structure
(A) Mapping of Aut7 and Cvt9 binding domains within Cvt19 by a yeast two-hybrid system. The cvt19 test strain (WHY4) was transformed
with the binding domain plasmid containing the entire CVT9 or AUT7 ORF (pGBD-Cvt9 or pGBD-Aut7, respectively) and the activation domain
plasmid containing wild-type or mutant CVT19. Transformants were selected on SC-Leu-Ura plates (data not shown) and replicated to SC-
Ade plates. The figures show cells grown at 30C for 2 days.
(B) A protein A-Aut7R affinity isolation experiment was performed in lysates from the apg1 cvt19 strain expressing full-length Cvt19 or
the indicated truncate. C-terminal deletion of Cvt19 compromised its coisolation with Aut7.
(C) Cvt9 interacts with the C terminus of Cvt19. Total lysates from apg1 cvt19 cells expressing HA-Cvt9 and either wild-type or mutant
Cvt19 fused with protein A (ProtA-Cvt19) were used to precipitate ProtA-Cvt19 proteins with IgG Sepharose. The left and right panels show
the protein blots of total cell lysates (Lysate) and the IgG precipitates (Bound), respectively, which were probed with anti-HA antibody.
(D and E) Localization of GFP-Ape1 (D) or GFP-Cvt19 (E) in the aut7, cvt9, and aut7 cvt9 strains by fluorescence and DIC microscopy.
Bar, 5 m.
(F and G) Colocalization of CFP-Ape1 with YFP-Aut7 (F) or YFP-Cvt19 (G) in the cvt9 strain by fluorescence and DIC microscopy. Bar, 5 m.
still occurs in starved aut7 cells. In contrast, the cvt9 that Cvt9 could be another binding partner of Cvt19. To
test this possibility, we examined the interaction be-strain shows a relatively normal autophagic protein deg-
radation, whereas only a partial transport of prApe1 is tween Cvt9 and Cvt19 by a yeast two-hybrid system
and a protein A affinity isolation experiment. Two-hybridrestored by starvation, suggesting that Cvt9 plays an
important role in cargo selection in selective autophagy analysis revealed a significant interaction between Cvt9
and full-length Cvt19 (Figure 4A). Furthermore, Cvt19CC(Kim et al., 2001b). For this reason, we hypothesized
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Figure 5. Precursor Ape1 Is Required for the Efficient Transport of Cvt19 and the Cargo Protein Ams1
(A) Wild-type, apg1, ape1, and ams1 cells were pulse labeled for 10 min in SMD medium and chased for the indicated times in SMD
medium. Ape1 and Cvt19 were immunoprecipitated from cell extracts and analyzed by SDS-PAGE.
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still displayed a significant interaction, indicating that greater than that in wild-type cells (Scott et al., 2001).
This led us to examine whether another cargo protein,the coiled-coil domain was not necessary for the interac-
tion with Cvt9 (data not shown). We therefore subjected -mannosidase (Ams1), could affect the import of Cvt19.
We performed a pulse-chase experiment to monitor theseveral C-terminal deletion mutants of Cvt19 to two-
hybrid analysis and found that Cvt1910C, Cvt1915C, and transport of prApe1 and Cvt19 to the vacuole. In ams1
cells, however, Cvt19 degradation was comparable toCvt1920C were able to interact with Cvt9, whereas
Cvt1928C no longer exhibited this interaction (Figure 4A). that in wild-type cells (Figure 5A). In addition, the dele-
tion of AMS1 did not lead to any alteration in prApe1This result led us to test the Cvt19 mutant lacking the
8-amino acid region from amino acid residues 388 to processing (Figure 5A). These results were supported
by fluorescence microscopy, which showed normal lo-395 (Cvt1921–28C). As expected, Cvt1921–28C did not show
any interaction (Figure 4A), suggesting that the Cvt9 calization of GFP-Cvt19 and GFP-Ape1 in ams1 cells
(Figure 5B). Conversely, Cvt19 was stabilized in ape1binding domain might be located within this 8-amino
acid region. Because Aut7 was able to associate with cells, similar to the result seen in apg1 cells (Figure
5A), in agreement with previous studies (Scott et al.,Cvt1921–28C (Figure 4A), the binding domains for Aut7
and Cvt9 could be separated (Figure 6A). 2001). These results indicated that prApe1, but not
Ams1, was required for proper import of Cvt19 to theTo extend the analysis, we next performed affinity
isolation experiments from the lysates of apg1 cvt19 vacuole. To further investigate the effects of prApe1 on
Cvt19 import, we compared the localization of GFP-cells expressing each protein A-fused Cvt19 derivative
and HA-tagged Cvt9. In contrast to the data from the Cvt19 in apg1 and ape1 cells. As expected from the
GFP-Ape1 localization in apg1 cells, GFP-Cvt19 wastwo-hybrid analysis, we were unable to detect a physical
interaction between any mutant and HA-Cvt9, whereas also concentrated at the site adjacent to the vacuole in
the apg1 strain (Figure 5B). In contrast, in ape1 cells,wild-type Cvt19 was able to coprecipitate HA-Cvt9 (Fig-
ure 4C). This discrepancy between two-hybrid and affin- GFP-Cvt19 was distributed uniformly in the cytoplasm
(Figure 5B), consistent with the dispersed distributionity isolation analyses could result from the difference in
the sensitivities of the assays; the recovery of HA-Cvt9 of GFP-Cvt19263C and GFP-Cvt19CC lacking the prApe1
binding domain (Figure 3D). Altogether, these resultswas quite poor, even from the wild-type Cvt19 strain.
The microscopy of the cvt9 cells expressing GFP-Ape1 suggested that the Ape1 complex concentrated Cvt19
through the interaction between prApe1 and Cvt19.or GFP-Cvt19 revealed that both proteins were highly
concentrated away from the vacuole (Figures 4D and The transport of Ams1 to the vacuole is also defective
in the cvt19 strain, demonstrating that Cvt19 is the4E). Similarly, GFP-Cvt1921–28C accumulated away from
the vacuole (Figure 3D). These results strongly sug- receptor for both prApe1 and Ams1 (Scott et al., 2001).
Because of decreased import of Cvt19 in ape1 cells,gested that the loss of the PAS localization of Cvt19
deletion mutants resulted from the disruption of the Ams1 transport to the vacuole could also be reduced.
To test this hypothesis, we constructed GFP-Ams1 un-physical interaction between Cvt19 and Cvt9. Further-
more, we confirmed that CFP-Ape1 colocalized with der the control of the endogenous AMS1 promoter and
examined its localization in several mutant strains byYFP-Cvt19, but not with YFP-Aut7, in the cvt9 strain
(Figures 4F and 4G). These results indicate that, in the fluorescence microscopy. In rich medium, this construct
gave a vacuolar staining with a few tiny dots in thecvt9 strain, prApe1 and Cvt19 formed a protein com-
plex that was unable to reach the PAS. Consequently, perivacuolar region in the wild-type strain (Figure 5C).
Induction of autophagy by starvation or rapamycin treat-we concluded that the disruption of the association be-
tween Cvt19 and Cvt9 prevented the prApe1-Cvt19 ment gave a similar result but made the vacuolar signal
brighter (data not shown). In addition, several tiny dotscomplex from localizing to the PAS. Because GFP-Ape1
and GFP-Cvt19 displayed the same localizations in of GFP-Ams1 were observed in the vacuolar lumen in
pep4 cells (data not shown), suggesting that GFP-aut7 cvt9 cells to those in cvt9 cells (Figures 4D
and 4E), Cvt9 might function at an earlier step than Aut7 Ams1 was incorporated in Cvt vesicles. When Cvt vesi-
cle formation was blocked by deleting APG1, GFP-Ams1in the recruitment of this complex to the PAS.
accumulated in the perivacuolar region (Figure 5C). In
contrast, the deletion of CVT19 or APE1 caused GFP-The Cargo Protein prApe1 Directs the Cvt19
Receptor and Another Cargo Protein Ams1 Ams1 signals to be dispersed in the cytoplasm (Figure
5C), indicating that prApe1 and Cvt19 are required totoward Incorporation into Cvt Vesicles
Cvt19 is degraded as a consequence of import into the localize Ams1 to both the vacuole and the perivacuolar
structure. Because GFP-Ams1 still showed a cytosolicvacuole, and its half-life in ape1 cells is four times
(B) Localization of GFP-Ape1 or GFP-Cvt19 in wild-type, ams1, apg1, and ape1 strains by fluorescence and DIC microscopy. Bar, 5 m.
(C) Localization of GFP-Ams1 in wild-type, apg1, cvt9, cvt19, and ape1 strains by fluorescence and DIC microscopy. Cells were grown
to midlog phase and labeled with FM 4-64 in SCD medium. Bar, 5 m.
(D) Ams1 associates with Cvt19, independent of Ape1. The apg1 or ape1 apg1 cells were transformed with pHA-Ams1 and pRS416-
CuProtA or pCuProtA-Cvt19. IgG Sepharose was used to precipitate ProtA-Cvt19 from cell lysates. The left and right panels show the protein
blots of total cell lysates (Lysate) and the IgG precipitates (Bound), respectively, which were probed with anti-HA antibody.
(E) The Ams1 binding site in Cvt19 is different from the prApe1 binding site. Total lysates from apg1 cvt19 cells expressing HA-Ams1 and
either ProtA-Cvt1928C or ProtA-Cvt19224C were used to precipitate ProtA-Cvt19 proteins with IgG Sepharose. Total cell lysates (Lysate) and
the IgG precipitates (Bound) were analyzed by Western blot with anti-HA or anti-Ape1 antisera.
(F) Colocalization of YFP-Ams1 with CFP-Ape1 or CFP-Cvt19 in apg1 and cvt9 cells by fluorescence and DIC microscopy. Bar, 5 m.
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Figure 6. Model for Selective Targeting of
Cvt Cargos into the Cvt Vesicle
(A) Schematic drawing of binding domains in
Cvt19. The prApe1 binding domain (blue) is
located in the region from amino acid resi-
dues 153 to 191, which contains the predicted
coiled-coil motif. The 10-amino acid region
from 406 to 415 (yellow) and the 8-amino acid
region from 388 to 395 (green) are for Aut7
binding and Cvt9 binding, respectively. An
exact binding domain for Ams1 has not been
determined but is located in a region within
amino acid residues 192–387 (red arrow).
(B) After prApe1 is synthesized it immediately
forms dodecamers in the cytosol, which are
further assembled into an Ape1 complex de-
pendent on its propeptide. Cvt19 then binds
to the Ape1 complex, which is also mediated
by the prApe1 propeptide. Because Ams1 is
able to associate with Cvt19 via a domain
distinct from the prApe1 binding domain,
Ams1 could be concentrated on the Ape1
complex as a consequence of the Ape1-
Cvt19 complex formation. Cvt9 then interacts
with the C terminus of Cvt19 to recruit the
Ape1-Cvt19-Ams1 complex to the PAS,
where Aut7 binds to the extreme C terminus
of Cvt19 to ensure the incorporation of the
complex into the Cvt vesicle. See text for de-
tails.
distribution in cvt19 apg1 and ape1 apg1 strains Discussion
(data not shown), Cvt19 and prApe1 appear to function
in Ams1 transport at an earlier step than Apg1. Although Precursor aminopeptidase I has been used as a marker
GFP-Ams1 accumulated as a prominent dot in cvt9 for both the biosynthetic Cvt pathway and autophagy
cells, it did not localize close to the vacuole (Figure 5C). (Baba et al., 1997). Immunoelectron microscopy and
Furthermore, we observed that YFP-Ams1 colocalized biochemical studies showed that cytosolic prApe1 as-
with CFP-Ape1 or CFP-Cvt19 in both apg1 and cvt9 sembled into a large Cvt complex composed of prApe1
strains (Figure 5F), suggesting that Ams1 is accumulated dodecamers (Baba et al., 1997; Kim et al., 1997). Re-
on the Ape1-Cvt19 complex. cently, we showed that Cvt19 acts as a receptor through
To elucidate whether the accumulation of Ams1 on its interaction with the prApe1 propeptide (Scott et al.,
the Ape1-Cvt19 complex is dependent on the interaction 2001). Cvt19 also functions as a receptor for a second
between Ams1 and Cvt19, we performed a protein A cargo of the Cvt pathway, Ams1 (Hutchins and Klionsky,
affinity isolation experiment from the lysate of the apg1 2001; Scott et al., 2001). Along with Cvt19, most of the
cells expressing protein A-Cvt19 and HA-tagged Ams1. other proteins of the Cvt and Apg pathways localize to
As shown in Figure 5D, HA-Ams1 was copurified with a punctate perivacuolar preautophagosomal structure.
protein A-Cvt19 from the apg1 cell lysate. Together However, until now, nothing more has been known about
with the data from Figure 3, this result suggested the the nature of the interaction between Cvt19 and its car-
formation of an Ape1-Cvt19-Ams1 complex. Further- gos or between these proteins and other Apg/Aut/Cvt
more, we found that the Ams1-Cvt19 interaction still components. In order to learn more about the mecha-
existed, even in ape1 apg1 cells, where Ams1 was nism of the Apg/Cvt pathways, we constructed a GFP-
dispersed in the cytoplasm (Figure 5D), suggesting that
Ape1 chimera that could be used to follow the Cvt com-
Ams1 and Cvt19 could form a cargo-receptor complex
plex in vivo. GFP-Ape1 was delivered to the vacuolethat then interacts with the Ape1 complex. If it is possible
and processed in a Cvt pathway- and Pep4-dependentto form the Ape1-Cvt19-Ams1 complex, the binding
manner, indicating that it is a valid marker for the Cvtsites for prApe1 and Ams1 within Cvt19 should be lo-
complex.cated in different places. To test this, we performed the
Our analyses of GFP-Ape1, together with affinity isola-protein A affinity isolation from lysates of the apg1
tion experiments, have allowed us to propose a modelcvt19 cells expressing HA-Ams1 and protein A-Cvt1928C
for the selective targeting of cargo proteins through theor protein A-Cvt19224C. Western blot analysis of the re-
Cvt and autophagy pathways. (1) Precursor Ape1 oligo-sulting precipitants revealed that protein A-Cvt1928C
mers assemble into a higher-order structure, the Ape1was able to pull down both prApe1 and Ams1, whereas
complex, in a propeptide-dependent manner. (2) Aonly prApe1 was precipitated with protein A-Cvt19224C
Cvt19-Ams1 complex concentrates at the Ape1 complex(Figure 5E). This result indicated that Ams1 associated
through the interaction between precursor Ape1 andwith Cvt19 via a site that is distinct from the prApe1
binding site (Figure 6A). Cvt19. (3) Subsequently, Cvt9 recognizes a C-terminal
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domain of Cvt19 to target the Ape1-Cvt19-Ams1 com- the Cvt complex by Cvt9, the complex can be targeted
to the PAS through the possible interaction betweenplex to the site of Cvt vesicle formation. (4) Finally, the
complex is incorporated into the Cvt vesicle through Cvt9 and the PAS components (Figure 6B, step IV). Two
candidates for the acceptor on the PAS are Apg1 and/interaction with Aut7.
or Apg12 because Cvt9 showed physical interactions
with these PAS components (Kamada et al., 2000; KimAssembly and Recognition of the Cargo Complex
et al., 2001b; Ho et al., 2002). We have also mapped aPreviously we have shown that prApe1 rapidly assem-
fourth distinct domain within Cvt19 that binds Aut7. Afterbles into a dodecamer in the cytosol and that the prApe1
arrival of the Cvt9-Cvt19-cargo complex at the PAS,propeptide contains vacuolar targeting information (Oda
the Cvt19-cargo complex can be transferred to Aut7 toet al., 1996; Kim et al., 1997). Formation of the Cvt com-
ensure the incorporation of the Cvt complex into theplex allows Cvt cargos to be effectively packaged by a
Cvt vesicle (Figure 6B, step V). Although it is not clearlimited membrane source. However, nothing had been
whether Cvt9 is released from the complex at this step,reported about the molecular property and the formation
we speculate that it may be released, because GFP-mechanism of the Cvt complex. In this study, we have
Cvt9 did not reach the vacuole (Kim et al., 2001b).dissected the process of Cvt complex formation into
two steps and found that both steps require the function
of the prApe1 propeptide. In the first step, prApe1 dode- Mechanism for Selective Autophagy
camers assemble into the Ape1 complex (Figure 6B, Macroautophagy, pexophagy, and the Cvt pathway
step I). Although no evidence has been provided about share common machinery for vesicle formation and pos-
whether another protein is required at this step, the sess a few specific factors for induction, cargo selection,
cytosolic hsp70 family protein, Ssa1, could be one of and supply of the source membrane (Reggiori and Klion-
the candidates. It was reported that Ssa1 specifically sky, 2002). Cvt9 is required for pexophagy in yeast as
associates with the prApe1 propeptide and is required well as the Cvt pathway, suggesting that pexophagy
for the targeting of prApe1 to the Cvt vesicle, but not and the Cvt pathway further share similar mechanisms
for assembly into a dodecamer (Silles et al., 2000). In for cargo selection (Kim et al., 2001b; Scott et al., 2001).
the second step, the propeptide interacts with the Cvt19 In the Cvt pathway, Cvt9 recognizes Cvt19 on the “sur-
receptor, thus defining a function in formation of the Cvt face” of the Cvt complex. Because of the size of the
complex (which we define as the Cvt19-cargo complex; Cvt complex, this interaction is similar to recognition of
Figure 6B, step II). The interaction between prApe1 and an organelle. Similarly, Cvt9 might be able to recognize
Cvt19 is mediated by the predicted coiled coil of Cvt19. some signal on the peroxisome and bring it to the site
Interestingly, the loss of Cvt19’s coiled coil or the dele- of vesicle formation. Alternatively, Cvt9 might bind a
tion of APE1 itself led to the cytosolic localization of receptor like Cvt19 that is specific for peroxisomes.
Cvt19, indicating that the cargo (Ape1) complex concen- The mechanism of cargo selection in the Cvt pathway
trates the receptor (Cvt19) proteins rather than vice provides insight into the selective autophagy of organ-
versa (Figure 6B, step II). In addition, another Cvt cargo, elles in mammalian cells as well as yeast cells. Excess
Ams1, is also concentrated at the Cvt complex as a organelles induced under specific conditions or dam-
consequence of the association with Cvt19 (Figure 6B, aged organelles are specifically removed by autophagy
step I). A defect in Ape1-Cvt19 complex formation se- (Luiken et al., 1992; Tolkovsky et al., 2002). The specific
verely affected the import of Ams1 to the vacuole, removal of damaged organelles may play important
whereas Ams1 was dispensable for the transport of the roles in preventing premature aging or apoptosis (Brunk
Ape1-Cvt19 complex, indicating that Ams1 might exploit and Terman, 2002; LeMasters et al., 1998). Damaged
the prApe1 import system to achieve its own effective organelles may present an epitope on their surfaces
transport to the vacuole. that is recognized by PAS components. Because a Cvt9
counterpart is not found in mammalian cells, other pro-
teins that provide a link between cargo and the PASTargeting of the Cvt Complex to the Site
of Vesicle Formation components may exist, or a PAS component may di-
rectly recognize cargos in mammalian cells.Cvt9 localizes to the PAS, the site of Cvt vesicle/auto-
phagosome formation, and is required for the Cvt path- The majority of the Apg/Aut/Cvt proteins have been
localized to the PAS. However, little is known aboutway and pexophagy, but not for nonspecific autophagy,
suggesting that Cvt9 plays a role in the recognition of the function of most of these proteins, and essentially
nothing is known about the temporal order of action.specific cargos (Kim et al., 2001b). Several lines of evi-
dence strongly suggest that Cvt9 is involved in the tar- We have shown that, in the absence of Cvt19, prApe1
is not able to localize to the PAS. In cells lacking Cvt9,geting of the Cvt complex to the PAS and acts like an
adaptor protein. (1) Cvt9 physically interacted with the Cvt19 and prApe1 bind each other but, again, do not
localize to the PAS. Finally, in aut7 cells, the Ape1-C-terminal region of Cvt19. (2) When the Cvt19 domain
responsible for Cvt9 binding was deleted, the Cvt com- Cvt19-Ams1 complex can localize to the PAS but cannot
import into the vacuole. These results indicate thatplex was no longer seen at the PAS. (3) Similarly, in the
cvt9 strain, the Cvt complex did not localize at the Cvt19 and Cvt9 first act not at the PAS, but at the site
of Ape1 complex formation in the cytosol. Furthermore,PAS. How Cvt9 guides the Cvt complex to the PAS
remains to be solved. We propose that Cvt9 forms a we have determined a specific order of interaction for
Cvt19, Cvt9, and Aut7. Future studies will extend thisstable interaction with the Cvt complex prior to targeting
to the PAS (Figure 6B, step III). After the recognition of analysis to determine the way in which Cvt complex
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Table 1. Yeast Strains Used in This Study
Strain Descriptive Name Genotype Reference
SEY6210 wt MAT his3-200 leu2-3,112 lys2-801
trp1-901 ura3-52 suc2-9 GAL Robinson et al., 1988
AHY001 cvt9 SEY6210; cvt9::HIS3 Kim et al., 2001b
SSY31 cvt19 SEY6210; cvt19::HIS5 S.p. Scott et al., 2001
THY411 ams1 SEY6210; ams1::LEU2 Hutchins and Klionsky, 2001
WHY1 apg1 SEY6210; apg1::HIS5 S.p. This study
WPHYD7 aut7 SEY6210; aut7::LEU2 Kim et al., 2001a
YTS107 ape1 SEY6210; ape1::LEU2 This study
WHY3 aut7 cvt9 SEY6210; aut7::URA3 cvt9::HIS3 This study
WHY2 ape1 apg1 SEY6210; ape1::LEU2 apg1::HIS5 S.p. This study
YTS108 ape1 cvt19 SEY6210; ape1::LEU2 cvt19::HIS5 S.p. This study
TVY1 pep4 SEY6210; pep4::LEU2 Gerhardt et al., 1998
YTS112 ape1 pep4 TVY1; ape1::HIS5 S.p. This study
YTS106 apg1 cvt19 MATa his3 leu2 trp1 ura3 apg1::LEU2
cvt19::HIS5 S.p. This study
PJ69-4A wt MATa trp1-901 leu2-3,112 ura3-52
his3-200 gal4 gal80 LYS2::GAL1-HIS3
GAL2-ADE2 met2::GAL7-lacZ James et al., 1996
WHY4 cvt19 PJ69-4A; cvt19::KanMX4 This study
YTS110 ape1 PJ69-4A; ape1::HIS5 S.p. This study
YTS111 cvt19 PJ69-4A; cvt19::HIS5 S.p. This study
protein G-Sepharose 4 Fast Flow (Amersham Pharmacia Biotech)formation and binding to the PAS is coordinated with
for 1 hr at 4C. After washing the Sepharose with lysis buffer fourformation of the sequestering vesicle, the hallmark of
times, the bound materials were eluted by boiling the Sepharose inthe Cvt and Apg pathways.
SDS-PAGE loading buffer. The resulting eluate was analyzed by
Western blot with anti-Ape1 (Klionsky et al., 1992) or polyclonal anti-
Experimental Procedures
HA (Santa Cruz Biotechnology) antisera.
For protein A-Cvt19 affinity isolation, cell extract prepared as
Strains and Media
described above was incubated with IgG Sepharose 6 Fast Flow
The yeast Saccharomyces cerevisiae strains used in this study are
(Amersham Pharmacia Biotech) for 1 hr at 4C. After washing with
listed in Table 1. Media used for growing yeast, YPD, synthetic minimal
lysis buffer four times, the bound materials were eluted by boiling the
(SMD), synthetic complete (SC), and synthetic with casamino acids
Sepharose in SDS-PAGE loading buffer and analyzed by Western
(SCD) media are described elsewhere (Adams et al., 1998; Scott et
blotting with anti-Ape1 or anti-HA antiserum. Protein A-Aut7R affin-
al., 2001; Suzuki et al., 2001). Copper was not added to media, even
ity isolation was performed essentially as previously described (Kim
when expressing genes under the control of the CUP1 promoter.
et al., 2002).
Pulse-chase analyses and measurements of -galactosidase ac-
Plasmid Construction
tivity were performed as previously described (Klionsky et al., 1992;
The following method was used to make fluorescent protein or triple
Scott et al., 1996; Adams et al., 1998).
haemagglutinin (HA)-tagged constructs for Ape1, Ams1, and Cvt19.
The BglII (for APE1 and CVT19) or BamHI (for AMS1) restriction site
Fluorescence Microscopywas introduced just after the initiation codon of each gene on
Cells expressing fluorescent protein-fused chimeras were grown inpRS414 or pRS416 with a QuikChange Site-Directed Mutagenesis
SCD medium to midlog phase. To label the vacuolar membrane, weKIT (Stratagene). The DNA fragment encoding GFP (S65T), EYFP,
incubated cells in the medium containing 16 M N-(3-triethylammo-ECFP, or HA cassette with BamHI or BglII sites on both sides was
niumpropyl)-4-(p-diethylaminophenylhexatrienyl) pyridinium dibro-then ligated to the newly generated BglII or BamHI site of each
mide (FM 4-64; Molecular Probes) at 30C for 20 min. After beinggene, to make the respective fusion constructs. For the truncated
washed with medium, the cells were incubated in the medium atversions of pGFP-Cvt19 and pYFP-Cvt19, the truncated ORFs were
30C for 2 hr. Fluorescence microscopy analysis was performed withPCR-amplified and ligated into pRS416 containing the CVT19 pro-
a Nikon E-800 fluorescent microscope equipped with a Hamamatsumoter, GFP/YFP, and the CYC1 terminator. For the generation of the
Orca2 digital camera as previously described (Kim et al., 2002).protein A-Cvt19 fusion and its deletion versions, a PCR product con-
taining full-length or deleted CVT19 ORF was inserted into the EcoRI/
AcknowledgmentsSalI site of pRS416-CuProtA (Kim et al., 2002). For two-hybrid analy-
sis, we used a system developed by James et al. (1996). pGBD-Ape1,
We would like to thank Dr. Yoshinori Ohsumi for providing pYFP-pGBD-Aut7, and pGBD-Cvt9 were constructed as bait plasmids by
Aut7 and pCFP-Aut7. We also wish to thank Dr. Fulvio Reggiori andligating the full-length APE1, AUT7, and CVT9 ORFs, respectively,
Chao-Wen Wang for helpful discussions and technical advice. Thisinto pGBDU-C1. The prey plasmid pGAD-Cvt19 or its truncates were
work was supported by National Institutes of Health Public Healthconstructed by ligating the full-length or the truncated CVT19 ORFs
Service grant GM53396 to D.J.K.into pGAD-C2. Other plasmids have been described elsewhere (Oda
et al., 1996; Kim et al., 2002; Suzuki et al., 2001).
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